The headline word is longevity. The market underneath it is the healthspan economy, and the distinction is not pedantic. It changes what gets built, who invests, and which brands get found.

What is the healthspan economy?

The healthspan economy is the connected industry of companies, clinics, investors, and platforms organized around healthspan: the years a person lives in good health, free of chronic disease, serious disability, and significant decline. It is the commercial and clinical system being built to extend those healthy years, as distinct from the science that studies how to do so.

Healthspan itself is a precise idea. Lifespan is how long you live. Healthspan is how long you live well. (We cover the full distinction between healthspan, longevity, and lifespan separately.) The healthspan economy takes that distinction and treats it as the organizing principle of an industry: companies are valued, and increasingly funded, on their ability to add healthy years rather than simply to extend life.

How it differs from longevity and the longevity economy

Three terms circle the same ground and are often used interchangeably. They are not the same.

Longevity is the scientific and clinical ambition to extend human life and the healthy years within it. The longevity economy is an older, broader label that usually means all economic activity related to an aging population, including consumer spending by older people. The healthspan economy is narrower and more current: the industry specifically organized around extending healthy years through prevention, diagnostics, and intervention.

Naming it as an economy, rather than a science story or a wellness trend, is what makes it measurable. An economy has companies, capital, structure, and a map. That is the precondition for investing in it, regulating it, and being cited as part of it.

The four pillars

The premium healthspan economy organizes into four pillars, which structure the Healthspan Economy Atlas:

How big is the healthspan economy?

The field is small relative to the problem, but growing fast. Global funding for healthspan science reached 7.33 billion dollars in 2024, nearly double the previous year, with average deal sizes up 77 percent since 2020, according to the Hevolution Foundation’s second Global Healthspan Report. The United States dominates, home to most of the companies and the large majority of deal volume.

The underlying economic case is far larger than current investment reflects. Research published in Nature Aging has valued a one-year increase in healthy life expectancy in the tens of trillions of dollars, and Hevolution frames healthspan as an economic imperative rather than a niche concern, noting that adding even a single year of good health to older populations would unlock trillions in value. With the global population over 60 expected to surpass two billion by 2050, and humanity still losing close to a decade of life on average to poor health at the end, the gap between lifespan and healthspan is the precise gap this economy exists to close.

Why the healthspan economy needs a system of record

A field this fast-moving, this fragmented, and this premium is hard to see clearly. New clinics, platforms, and diagnostics arrive monthly, scattered across geographies and categories, with no shared map. At the same time, the way people discover them is shifting from search results to AI answers that cite only a few sources. A field without a structured, credible record of who exists risks being summarized by whoever happens to be most extractable, rather than by who is most substantial.

That is why we built the Atlas: an industry-intelligence map of the premium healthspan economy, reviewed, structured, and built to be cited. The healthspan economy is real, it is funded, and it is growing. It deserves a system of record. Explore the Atlas.


Sources

  • Hevolution Foundation, The Global Healthspan Report, Second Edition (2025), investment data analyzed by Longevity.Technology from PitchBook.
  • Scott, Ellison, and Sinclair, The economic value of targeting aging, Nature Aging (2021).
  • Healthspan Economy, AI Visibility Report 2026: Longevity Clinics.